CAR-T Cell Therapy for HIV Cure: Current Challenges, Advances and Future Directions
Viruses · 14.12.2025 · 17 (12) · 1615
DOI: 10.3390/v17121615 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 14.12.2025. Verfasst von Monica-Daniela Padurariu-Covit und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Medicine and Pharmacy Faculty, "Dunarea de Jos" University of Galati, 800008 Galati, Romania. Hauptthemen laut MEDLINE: HIV Infections, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Dunarea de Jos” University.
Abstract (Originalsprache)
Antiretroviral therapy (ART) effectively suppresses HIV replication but fails to eradicate latent reservoirs, leading to viral rebound after interruption. Chimeric antigen receptor (CAR) T-cell therapy offers a potential strategy to achieve durable remission. A systematic PubMed search (July 2020–June 2025) identified 253 studies on CAR-T therapy in HIV; 74 met inclusion criteria and were qualitatively analyzed. Preclinical data showed that CAR-T cells can recognize and eliminate infected cells, reach viral reservoirs, and persist long term, particularly when derived from hematopoietic stem cells. Dual-target and combination approaches with checkpoint inhibitors or latency-reversing agents enhanced antiviral efficacy. Early clinical studies confirmed safety and modest reservoir reduction. CAR-T cell therapy represents a promising step toward a functional HIV cure. Further optimization of design, integration with gene-editing technologies, and standardized clinical evaluation are required to confirm durable efficacy and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, Medicine and Pharmacy Faculty, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
- Department of Hematology, Emergency County Hospital Sf. Apostol Andrei, 800578 Galati, Romania.
- Department of Pharmaceutical Sciences, Medicine and Pharmacy Faculty, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
- Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania.
- Department of Hematology, Colentina Clinical Hospital, 050098 Bucharest, Romania.
- Department of Clinical Surgery, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
ORCID-Profile: Monica-Daniela Padurariu-Covit, Mihaela Andreescu, Catalin Plesea-Condratovici, Manuela Arbune
Förderung
- “Dunarea de Jos” University
Zitieren
APA
Padurariu-Covit, M. D., Georgescu, C., Andreescu, M., Chiscop, I., Plesea-Condratovici, C., & Arbune, M. (2025). CAR-T Cell Therapy for HIV Cure: Current Challenges, Advances and Future Directions. Viruses, 17(12), 1615. https://doi.org/10.3390/v17121615
Vancouver
Padurariu-Covit MD, Georgescu C, Andreescu M, Chiscop I, Plesea-Condratovici C, Arbune M. CAR-T Cell Therapy for HIV Cure: Current Challenges, Advances and Future Directions. Viruses. 2025;17(12):1615. doi:10.3390/v17121615
BibTeX
@article{PadurariuCovit2025,
author = {Padurariu-Covit, Monica-Daniela and Georgescu, Costinela and Andreescu, Mihaela and Chiscop, Iulia and Plesea-Condratovici, Catalin and Arbune, Manuela},
title = {CAR-T Cell Therapy for HIV Cure: Current Challenges, Advances and Future Directions},
journal = {Viruses},
year = {2025},
volume = {17},
number = {12},
pages = {1615},
doi = {10.3390/v17121615}
}
EUVIMED